88901-38-6

Basic information

• Product Name: MogrosideIIE
• Synonyms: (3beta,9beta,10alpha,11alpha,24R)-11,25-Dihydroxy-9-methyl-19-norlanost-5-ene-3,24-diyl bis-beta-D-glucopyranoside
• CAS NO: 88901-38-6
• Molecular Formula: C42H72O14
• Molecular Weight: 801.017
• Product Categories: Miscellaneous Natural Products
• Mol File: 88901-38-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: MogrosideIIE(CAS DataBase Reference)
• NIST Chemistry Reference: MogrosideIIE(88901-38-6)
• EPA Substance Registry System: MogrosideIIE(88901-38-6)

Safety Data

• Hazardous Substances Data: 88901-38-6(Hazardous Substances Data)

Usage

Description

MogrosideIIE, a naturally occurring chemical compound found in the fruit of the Siraitia grosvenorii plant, also known as monk fruit, is a type of triterpenoid saponin. This group of plant compounds is recognized for their potential health benefits. Notably, MogrosideIIE is an exceptionally sweet compound, surpassing the sweetness of regular table sugar, yet it contains zero calories and does not impact blood sugar levels. Its unique properties have led to its use as a natural sweetener in a variety of food and beverage products. Furthermore, MogrosideIIE is under investigation for its potential anti-inflammatory, antioxidant, and antidiabetic properties, as well as its capacity to address obesity, metabolic syndrome, and other health conditions. Ongoing research aims to uncover additional health benefits and applications for this promising compound.

Uses

Used in Food and Beverage Industry:
MogrosideIIE is used as a natural sweetener for its intense sweetness and zero-calorie profile, making it an ideal alternative to sugar in various food and beverage products.
Used in Health and Wellness Applications:
MogrosideIIE is being studied for its potential use as an anti-inflammatory, antioxidant, and antidiabetic agent, due to its beneficial properties that may contribute to improved health and well-being.
Used in Obesity and Metabolic Syndrome Treatment:
MogrosideIIE is being explored for its potential role in treating obesity and metabolic syndrome, given its ability to support weight management and improve metabolic health without affecting blood sugar levels.
As research continues, additional applications for MogrosideIIE may be discovered, further expanding its use across different industries and health-related fields.